Immuneering Corp Income Statement

Income Statement Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 2.31M2.08M0.32M
Cost of Revenue 1.28M1.15M0.16M
Gross Profit 1.03M0.93M0.16M
Operating items
Amortization - Intangibles 0.03M0.03M
Research & Development 15.00M26.54M36.27M41.62M
Selling, General & Administrative 3.11M8.27M15.61M16.76M
Other Operating Expenses 0.03M0.03M
Operating Expenses 18.11M34.81M51.90M58.41M
Operating Income -17.08M-33.89M-51.74M-58.41M
EBIT -17.08M-33.89M-51.74M-58.41M
Non-operating items
Non Operating Investment Income -0.05M0.02M
Interest & Investment Income 0.04M0.17M1.01M3.61M
Other Non Operating Income -0.13M0.22M1.33M
Non Operating Income -0.13M0.22M1.33M
Net income details
EBT -17.04M-33.84M-50.51M-54.81M
Tax Provisions -0.31M
Profit After Tax -17.04M-33.54M-50.51M-53.47M
Income from Continuing Operations -17.04M-33.54M-50.51M-54.81M
Consolidated Net Income -17.04M-33.54M-50.51M-54.81M
Income towards Parent Company -17.04M-33.54M-50.51M-54.81M
Net Income towards Common Stockholders -17.04M-33.54M-50.51M-54.81M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 23.89M25.94M26.40M29.27M31.05M
Shares Outstanding (Diluted Average) 4.95M13.61M26.39M28.42M
EBITDA -17.04M-33.58M-50.49M-53.44M
Tax Rate 0.91%